Matsui H, Arai Y, Imoto H, et al. Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT. Blood Adv. 2020;4(13):3169-3179. | Blood Adv;8(7): 1698, 2024 Apr 09. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Matsui H, Arai Y, Imoto H, et al. Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT. Blood Adv. 2020;4(13):3169-3179.

Blood Adv ; 8(7): 1698, 2024 Apr 09.

Article in En | MEDLINE | ID: mdl-38551596

Subject(s)

Hematopoietic Stem Cell Transplantation; Thrombotic Microangiopathies; Humans; Thrombotic Microangiopathies/diagnosis; Thrombotic Microangiopathies/etiology; Thrombotic Microangiopathies/therapy; Risk Factors; Hematopoietic Stem Cell Transplantation/adverse effects

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Thrombotic Microangiopathies Limits: Humans Language: En Journal: Blood Adv Year: 2024 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Thrombotic Microangiopathies Limits: Humans Language: En Journal: Blood Adv Year: 2024 Document type: Article Country of publication: United States